PEGS China: Protein & Antibody Engineering and Development Summit
Event Date/Time: Apr 01, 2014 | End Date/Time: Apr 03, 2014 |
Early Registration Date: Feb 28, 2014 |
Description
Venue
Conference Speakers
Confirmed speakers include:
- Frank Bernhard, Ph.D., Lab Head, Institute of Biophysical Chemistry, Goethe University Frankfurt, Germany
- Chris Chen, Ph.D., SVP and Chief Technology Officer, Biologics Services, Wuxi Apptec
- Yan Chen, M.D., Ph.D., Senior Vice President, Research, X-BODY Biosciences, USA
- Ho Cho, Chief Technology Officer, Ambrx
- Danny Chou, PharmD, Ph.D., MBA, Senior Research Scientist, Biologics, Gilead Sciences, USA
- Partha Chowdhury, Ph.D., Principal Scientist, Antibody Discovery and Protein Engineering, MedImmune, LLC., USA
- Maria J. de Jesus, Ph.D., Co-Founder & COO, ExcellGene SA, Switzerland
- Davide de Lucrezia, Ph.D., CEO, Explora Biotech SRL, Italy
- Dimiter Dimitrov, Ph.D., Senior Investigator, Center for Cancer Research, NCI, NIH
- Changlin Dou, Ph.D., CTO, Luye Biologics, China
- Daotian Fu, Ph.D., Executive Vice President, Livzon MabPharm, Inc., China
- Ning Gao, Senior Scientist, AstraZeneca Pharmaceuticals, USA
- Matthias Germer, Ph.D., Senior Director, Preclinical Research, Biotest AG, Germany
- Tariq Ghayur, Research Fellow, Antibody Engineering, Abbvie, USA
- Rui Gong, Ph.D., Professor, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, China
- Ingo Gorr, Ph.D., Principal Scientist, Cell Culture Research, Large Molecule Research, Roche Diagnostics GmbH, Germany
- Ulf Grawunder, Ph.D. CEO, NBE-Therapeutics, enzyme assisted ADC conjugation
- Vaughn B . Himes, Ph.D., Executive Vice President, Process Sciences and Technical Operations, Seattle Genetics, USA
- Ian Hunt, Ph.D., Head of Protein Sciences, Center for Proteomic Chemistry, Novartis Institutes for Biomedical Research, USA
- Andrea Ji, Ph.D., Senior Scientist, Late Stage Pharmaceutical Development, Genentech, Inc.
- Shan Jiang, Ph.D., Director, Formulation and Fill/Finish, Seattle Genetics, Inc., USA
- Weidong Jiang, Ph.D., Chief Scientific Officer & VP, Henlius Biopharmaceuticals, Inc., USA
- Feng Tian, Ph.D., Head of Ambrx China
- Anand Khedkar, M. Tech, Chief Scientific Manager, R&D, Biocon Research Limited, India
- Dan Klassen, Founder, Klassen Consulting LLC & Associates
- Michael Lee, Vice President, Operations, DesigneRx Pharmaceuticals, Inc.
- Mark Perkins, Customer Technical Solutions Manager, Novozymes Biopharma UK Ltd., United Kingdom
- H Fai Poon, Ph.D., Director, Cell Culture, Hisun Pharmaceuticals, China
- Xueming Qian, Ph.D., Chairman and CEO, R&D, Mabspace Biosciences
- Arvind Rajpal, Ph.D., Vice President, Protein Engineering, Rinat
- Sai Reddy, Ph.D., Assistant Professor, Department of Biosystems Science and Engineering, ETH Zurich, Switzerland
- Mike Romanos, Ph.D., Chief Executive Officer, Crescendo Biologics, United Kingdom
- Johannes Salzbrunn, Head of Downstream Pilot, Process Science Microbials, Boehringer-Ingelheim RCV GmbH & Co. KG, Austria
- Li Shi, Ph.D., Chief Executive Officer, Shanghai Zerun Pharmaceuticals, China
- Shuangping Shi, Ph.D, Group Lead (Cell Line Development), BioProcess Development, Merck & Co., USA
- Daniel J. Sikkema, Ph.D., Executive Director, Biopharm R&D, Head of Clinical immunology, GlaxoSmithKline, USA
- Michela Silacci, Director Discovery Research, Covagen AG, Switzerland
- Stefanie Urlinger, Ph.D., Director R&D, Discovery Alliances Technologies, MorphoSys AG, Germany
- Prof. Florian Wurm, EPFL, mammalian cell expression engineering
- Xing Wang, Ph.D., President, Array Bridge
- Harald Wegele, Ph.D., Director, Development Analytics, Pharma Biotech Development, Roche Diagnostics GmbH, Germany
- Scott M. Wheelwright, Ph.D., Principal Consultant, Complya Asia Co., Ltd., China
- Florian M. Wurm, Ph.D, Professor of Biotechnology, Swiss Federal Institute of Technology, Switzerland
- Jingyi Xiang, Ph.D., Head of Bioanalytics, Eureka Therapeutics, Inc., USA
- Ting Xu, Ph.D., Chief Executive Officer, AlphaMab Co., Ltd., China
- Weiming Xu, Chief Executives Officer, Molecular Biology, London Biotech Ltd., United Kingdom
- Yiming Yang, Ph.D., Senior Scientist, Shire Human Genetic Therapies, USA
- Jin-San Yoo, President, PharmAbcine, Korea
- Lei Zheng, M.D., Ph.D., Assistant Professor, Oncology, John Hopkins University School of Medicine, USA
- Xiaoyang Zheng, Ph.D., Staff Scientist II, Analytical Development, Genzyme Corporation, a Sanofi Company
- Marie M. Zhu, Ph.D., Director of Process Sciences, Technical Operations, Agensys Inc., an Affiliate of Astellas Pharma Inc.
- Eugene Zhukovsky, Ph.D., Chief Scientific Officer, Affimed Therapeutics AG, Germany
Exhibits included
Current exhibitors include:
- Fluid Imaging Technologies
- Malvern Instruments
- MaxCyte, Inc.